VAERS reports by lot

GSK Varicella/Shingles lot 4FS5N: VAERS reports

51 VAERS reports list lot 4FS5N as a GSK Varicella/Shingles vaccine, received between 2018-09-08 and 2020-04-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6331%
Injection-site / Local reaction4019%
Neurological2613%
Musculoskeletal2110%
Cardiac / Cardiovascular157%
Gastrointestinal157%
Dermatological (non-injection-site)94%
Allergic / Anaphylactic73%
Respiratory63%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York9
Texas6
Pennsylvania5
Michigan3
Washington3
California2
Virginia2
Ohio2
North Carolina2
New Mexico2
Illinois1
Connecticut1

Reports by month received

2018-0926
2018-1011
2018-113
2018-121
2019-012
2019-023
2019-033
2020-011
2020-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.